Real-world cost-effectiveness of drug-eluting stents vs. bare-metal stents for coronary heart disease—A five-year follow-up study

Keyphrases

• Cost-effectiveness 100%
• 5-year Follow-up 100%
• Drug-eluting Stent 100%
• Bare Metal Stent 100%
• Stent 60%
• Cardiovascular Mortality 40%
• Percutaneous Coronary Intervention 40%
• Incremental Cost-effectiveness Ratio 40%
• Propensity Score Matching 20%
• National Health Insurance 20%
• Extraction Methods 20%
• Kaplan-Meier 20%
• Coronary Artery Disease 20%
• Cost-effective Strategy 20%
• Charlson Comorbidity Index 20%
• Medical Costs 20%
• Insurer 20%
• Retrospective Analysis 20%
• Sample Average 20%
• Coronary Patients 20%
• Stable Coronary Artery Disease 20%
• Claims Data 20%
• Longitudinal Health Insurance Database 20%
• Claims Database 20%
• Death Events 20%
• Coronary Events 20%

Medicine and Dentistry

• Cost-Effectiveness Analysis 100%
• Drug-Eluting Stent 100%
• Ischemic Heart Disease 75%
• Cardiovascular System 50%
• Health Care Cost 50%
• Percutaneous Coronary Intervention 50%
• Charlson Comorbidity Index 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Ischemic Heart Disease 100%
• Comorbidity 33%